Bomma Shilpa Revised's Insider Trades & SAST Disclosures

Visit FAQs

Bomma Shilpa Revised's most recent trade in Aurobindo Pharma Ltd. was a Disposal of 6,000 Equity Shares done at an average price of Rs. 998.7 . Disclosure was reported to the exchange on July 1, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for Bomma Shilpa Revised in the Trendlyne database.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Aurobindo Pharma
Bomma Shilpa (Revised) Other Disposal 01 Jul 2021 6,000 44,311 (0%) 0.00% 998.7 5,991,940 15 Jun 2021
16 Jun 2021		 Insider Trading Equity Shares Market Sale
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST